ORCHPHARMA.NS
Price:
$807.35
Market Cap:
$40.95B
Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins, veterinary products, and non-antibiotics. The company's multi-therapeutic presence in anti-infectives, anti-inflammatory, central nervous system, cardiovascular segment, nutraceuticals, and other oral and sterile products, as well as offers new drug discovery systems and pharmaceutical research and development services. It also exports its products to approximately 40 c...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2002-07-01
Stock Exchange
NSE
Ticker
ORCHPHARMA.NS
According to Orchid Pharma Limited’s latest financial reports and current stock price. The company's current ROE is 9.50%. This represents a change of 399.70% compared to the average of 1.90% of the last 4 quarters.
The mean historical ROE of Orchid Pharma Limited over the last ten years is -48.87%. The current 9.50% ROE has changed -119.43% with respect to the historical average. Over the past ten years (40 quarters), ORCHPHARMA.NS's ROE was at its highest in in the March 2023 quarter at 8.59%. The ROE was at its lowest in in the September 2013 quarter at -52.01%.
Average
-48.87%
Median
-5.08%
Minimum
-569.10%
Maximum
106.15%
Discovering the peaks and valleys of Orchid Pharma Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.33%
Maximum Annual ROE = 106.15%
Minimum Annual Increase = -2331.58%
Minimum Annual ROE = -569.10%
Year | ROE | Change |
---|---|---|
2024 | 7.88% | 17.17% |
2023 | 6.73% | -2331.58% |
2022 | -0.30% | -98.31% |
2021 | -17.85% | 4.30% |
2020 | -17.11% | 73.57% |
2019 | -9.86% | -122.13% |
2018 | 44.56% | -58.02% |
2017 | 106.15% | -118.65% |
2016 | -569.10% | 1.33% |
2015 | -39.80% | -59.35% |
The current ROE of Orchid Pharma Limited (ORCHPHARMA.NS) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
4.77%
5-year avg
-4.13%
10-year avg
-48.87%
Orchid Pharma Limited’s ROE is less than Jubilant Pharmova Limited (11.30%), greater than Solara Active Pharma Sciences Limited (-22.84%), less than Gland Pharma Limited (8.16%), greater than JSW Ispat Special Products Limited (-33.35%), greater than Panacea Biotec Limited (-0.97%),
Company | ROE | Market cap |
---|---|---|
11.30% | $143.74B | |
-22.84% | $23.77B | |
8.16% | $231.14B | |
-33.35% | $18.27B | |
-0.97% | $34.07B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Orchid Pharma Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Orchid Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Orchid Pharma Limited's ROE?
How is the ROE calculated for Orchid Pharma Limited (ORCHPHARMA.NS)?
What is the highest ROE for Orchid Pharma Limited (ORCHPHARMA.NS)?
What is the 3-year average ROE for Orchid Pharma Limited (ORCHPHARMA.NS)?
What is the 5-year average ROE for Orchid Pharma Limited (ORCHPHARMA.NS)?
How does the current ROE for Orchid Pharma Limited (ORCHPHARMA.NS) compare to its historical average?